Panc1 (krasgat)
Panc1 (krasgat) Uses, Dosage, Side Effects, Food Interaction and all others data.
Panc1 (krasgat) is under investigation in clinical trial NCT01676259 (A Phase 2 Study of Sig12d LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer).
Trade Name | Panc1 (krasgat) |
Generic | siG12D LODER |
siG12D LODER Other Names | Panc1 (krasgat), SiG12D LODER |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
![Panc1 (krasgat) Panc1 (krasgat)](https://www.medicinesfaq.com/media/png/panc1-krasgat.png)
Innovators Monograph
You find simplified version here Panc1 (krasgat)